Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.
Hrdina
P D
PD
Department of Pharmacology, University of Ottawa, Canada.
D000818:Animals; D000928:Antidepressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects; D003866:Depressive Disorder / Q000097:blood* / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D016666:Fluvoxamine / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D013329:Structure-Activity Relationship
D000928:Antidepressive Agents; D012702:Serotonin Antagonists; D012701:Serotonin; D016666:Fluvoxamine